Daily Roundup

Thursday, 19th November 2026 · updated 21:00

New Hope Corporation Returns Cash to Shareholders

New Hope Corporation is rewarding investors with a fully franked first interim dividend of 15 cents per share, payable on 10 February 2027. The record date is set for 29 January 2027, with the ex-dividend date falling on 28 January. The company is riding strong free cash flow generation and buoyant coal market conditions, and shareholders can expect a second interim dividend to follow later in the financial year. Those interested in reinvesting their dividends have until 1 February 2027 to elect into the Dividend Reinvestment Plan.

Chrysos Corporation Firing on All Cylinders

Mining technology company Chrysos Corporation is delivering impressive momentum heading into its AGM. The company's PhotonAssay technology processed a record 4.91 million samples in the first four months of FY27—a 43% jump year-over-year—driving revenue up 27% to $36.7 million. October alone saw a remarkable 1.36 million samples processed. The company has signed 15 new lease agreements, bringing its total contracted units to 973, and has deployed six new units with six more currently rolling out. With 514 units now operating across five continents, Chrysos is well-positioned for growth. The company reaffirmed its FY27 guidance of $108 million to $118 million in revenue and $35 million to $42 million in EBITDA, backed by a solid cash position of $19.5 million and $120 million in undrawn debt capacity.

Close the Loop Strengthens Its Balance Sheet

Close the Loop kicked off FY27 strongly, reporting Q1 revenue of $32.4 million and EBITDA of $4.3 million. The real story, though, is on the balance sheet. The company settled $24.4 million of convertible notes, slashing net debt to just $16.3 million. A refinancing deal with Citi Bank has been approved and should close by mid-December, which will trim interest costs and ease quarterly repayment pressures. Management remains confident in hitting the upper end of its FY27 EBITDA guidance of $14.0 million to $16.0 million. The company also announced a leadership shuffle, with Trifon Dimos stepping into the Chairman role while Grant Carman transitions to Non-Executive Director.

Emeco Expects Better Days Ahead

Equipment rental giant Emeco Holdings is seeing signs of improvement after a softer start to the calendar year. While utilisation dipped in early 2026, the company has already begun recovering in the second quarter of FY27 and expects this trend to accelerate through the second half. Emeco is guiding for Operating EBITDA between $275 million and $285 million for FY27, with a stronger weighting toward the latter half of the year. Capital expenditure is forecast at $155 million to $160 million net of asset disposals. The company is confident that improving utilisation will translate into earnings growth aligned with its 20% return on capital target by FY28.

BCAL Signals Support for GSS-MAP Merger

BCAL Diagnostics, the largest shareholder of Genetic Signatures, has thrown its weight behind the proposed merger with Microba Life Sciences—but with conditions attached. BCAL is prepared to support the deal on appropriate terms and would even consider funding MAP with up to $2 million for working capital, subject to its own capital raising. However, BCAL's backing hinges on a restructure of the GSS Board, including the resignation of the GSS Chair.

References